Testing effectiveness (Phase 2)WithdrawnNCT03811886
What this trial is testing
Natalizumab in Recurrent, Refractory or Progressive Pulmonary Metastatic Osteosarcoma
Who this might be right for
Pulmonary Metastatic Osteosarcoma (pOS)
Case Comprehensive Cancer Center